Takeda Development Center Americas Inc.: clinical-trial pipeline
Takeda Development Center Americas Inc. is the sponsor of 1,195 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 122 are not yet finished and 4 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials122
Phase 2/3 and 3351
Countries73
New in 90 days4
Trials by phase
| Phase | Trials |
|---|---|
| Phase 3 | 333 |
| Phase 1 | 269 |
| Not applicable | 257 |
| Phase 2 | 197 |
| Phase 4 | 75 |
| Phase 1/2 | 46 |
| Phase 2/3 | 18 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 913 |
| Terminated | 114 |
| Recruiting | 68 |
| Withdrawn or not authorised | 46 |
| Active, not recruiting | 37 |
| Not yet recruiting | 17 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 275 |
| Gastroenterology and liver | 184 |
| Metabolic and endocrine (diabetes, obesity) | 136 |
| Immunology and rheumatology | 124 |
| Cardiovascular | 109 |
| Rare and genetic diseases | 77 |
| Psychiatry and mental health | 55 |
| Nephrology and urology | 53 |
| Haematology | 52 |
| Infectious disease and vaccines | 47 |
| Neurology | 46 |
| Women's health and obstetrics | 20 |
Countries
| Country | Trials |
|---|---|
| United States | 558 |
| Japan | 272 |
| Germany | 153 |
| Spain | 150 |
| Canada | 142 |
| United Kingdom | 141 |
| Poland | 141 |
| Italy | 124 |
| France | 123 |
| China | 101 |
| Australia | 93 |
| Czechia | 91 |
| South Korea | 90 |
| Belgium | 89 |
| Hungary | 80 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-13 | New trial posted | A Study of Zasocitinib in Adults With Psoriatic Arthritis (LATITUDE PsA NeXt) |
| 2026-10-09 | New trial posted | A Study to Better Understand the Diagnosis and Treatment of Polycythaemia Vera |
| 2026-10-09 | New trial posted | A Study of Secondary Immunodeficiencies in Adults With Blood Cancers in Kazakhstan Who Ha… |
| 2026-08-31 | New trial posted | A Study of TAK-664 in People With Primary Immunodeficiency Diseases Who Have Not Yet Been… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06165341 | Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Diseas… | Phase 3 | Recruiting | Austria, Belgium, Canada, Switzerland +10 |
| NCT05816382 | A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions | Phase 2/3 | Active, not recruiting | Austria, Australia, Belgium, Switzerland +11 |
| NCT05319353 | A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for th… | Phase 3 | Recruiting | Australia, Belgium, Brazil, China +7 |
| NCT03589326 | A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia | Phase 3 | Active, not recruiting | Argentina, Austria, Australia, Bulgaria +15 |
| NCT06443502 | A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active… | Phase 3 | Not yet recruiting | Belgium, Czechia, Denmark, Spain +5 |
| NCT06233461 | A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Mod… | Phase 2 | Recruiting | Australia, Belgium, Bulgaria, Brazil +21 |
| NCT06254950 | A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Mod… | Phase 2 | Active, not recruiting | Australia, Belgium, Bulgaria, Canada +18 |
| NCT05442567 | A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) | Phase 3 | Recruiting | Australia, Belgium, Canada, China +14 |
| NCT04779320 | A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) | Phase 3 | Recruiting | Australia, Belgium, Canada, China +14 |
| NCT05582993 | A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD) | Phase 3 | Recruiting | Spain, France, United Kingdom, Ireland +3 |
| NCT05037760 | A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis | Phase 2 | Active, not recruiting | Australia, Brazil, Spain, France +3 |
| NCT04419649 | A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syn… | Phase 2 | Recruiting | Australia, Czechia, Germany, Spain +4 |
| NCT06100289 | A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease | Phase 3 | Recruiting | Belgium, Bulgaria, Switzerland, Denmark +12 |
| NCT06550076 | A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis | Phase 3 | Active, not recruiting | Argentina, Australia, Bulgaria, Canada +16 |
| NCT06227910 | A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease | Phase 3 | Not yet recruiting | Austria, Belgium, Brazil, Canada +22 |
| NCT06499285 | A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syn… | Phase 3 | Recruiting | Australia, Bulgaria, Brazil, Canada +21 |
| NCT06812078 | A Study of TAK-360 in Adults With Idiopathic Hypersomnia | Phase 2 | Recruiting | Spain, France, Hong Kong SAR China, Italy +2 |
| NCT06764615 | A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) | Phase 2 | Not yet recruiting | Belgium, Bulgaria, China, Czechia +13 |
| NCT06671496 | A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Med… | Phase 3 | Active, not recruiting | Argentina, Australia, Brazil, Canada +8 |
| NCT06671483 | A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines | Phase 3 | Active, not recruiting | Belgium, Bulgaria, Chile, Czechia +16 |
| NCT06747351 | A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropath… | Phase 3 | Recruiting | Argentina, Czechia, Germany, Denmark +7 |
| NCT06980480 | A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Mye… | Phase 3 | Recruiting | Austria, Australia, Brazil, Canada +14 |
| NCT06963827 | A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy | Phase 3 | Recruiting | Argentina, Austria, Australia, Canada +21 |
| NCT06405087 | A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's… | Phase 3 | Recruiting | Belgium, Bulgaria, Switzerland, Denmark +12 |
| NCT06722235 | A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia | Phase 3 | Recruiting | Australia, Bulgaria, China, Czechia +15 |
Website: takeda.com. All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Takeda Development Center Americas Inc. clinical trials: 122 open, 351 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/takeda-com/, data as of 2026-10-25.